Growth Metrics

Valion Bio (TIVC) Other Working Capital Changes (2021 - 2025)

Valion Bio has reported Other Working Capital Changes over the past 5 years, most recently at -$18000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 94.63% year-over-year to -$18000.0; the TTM value through Sep 2025 reached -$317000.0, down 296.25%, while the annual FY2023 figure was -$161000.0, 9.55% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$18000.0 at Valion Bio, up from -$95000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $160000.0 in Q2 2022 and troughed at -$335000.0 in Q4 2024.
  • A 5-year average of -$35200.0 and a median of -$18500.0 in 2023 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 628.26% in 2024 and later skyrocketed 4550.0% in 2025.
  • Year by year, Other Working Capital Changes stood at $34000.0 in 2021, then crashed by 226.47% to -$43000.0 in 2022, then dropped by 6.98% to -$46000.0 in 2023, then plummeted by 628.26% to -$335000.0 in 2024, then soared by 94.63% to -$18000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for TIVC at -$18000.0 in Q4 2025, -$95000.0 in Q3 2025, and $89000.0 in Q2 2025.